Theresa Hahn

12PUBLICATIONS
69CO-AUTHORS
Gene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursNanotoxicology, health and safetyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|Nov 14, 2025
Risk Factors beyond Chemotherapy Exposure for Secondary Myeloid Neoplasms after Hematologic Cancers: A SEER-Based Study.

Abhay Singh, Theresa Hahn, Rahul Mishra

|May 03, 2024
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall Survival.

Marcelo C Pasquini, Paul K Wallace, Brent Logan

|Feb 11, 2022
Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma.

Maximilian Merz, Almuth Maria Anni Merz, Jie Wang

Pageof 2